Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Environmental Science & Technology|September 19, 2025
The Susceptibility of Airborne SARS-CoV-2 to Far-UVC IrradiationDarryl M Angel, Irvan Luhung, Keyla S G de Sá, et al.Journal of Leukocyte Biology|May 8, 2019
Macrophage priming is dispensable for NLRP3 inflammasome activation and restriction of Leishmania amazonensis replicationRenan V H de Carvalho, Alexandre L N Silva, Leonardo L Santos, et al.Nature Communications|February 24, 2023
Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infectionKeyla S G de Sá, Luana A Amaral, Tamara S Rodrigues, et al.Life Sciences|March 30, 2021
Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patientsSimone R Potje, Tiago J Costa, Thais F C Fraga-Silva, et al.Plos Pathogens|June 5, 2024
Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19Keyla S G de Sá, Luana A Amaral, Tamara S Rodrigues, et al.The Journal of Infectious Diseases|February 10, 2023
CASP4/11 Contributes to NLRP3 Activation and COVID-19 ExacerbationTamara S Rodrigues, Camila C S Caetano, Keyla S G de Sá, et al.Science Advances|September 14, 2022
Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infectionLetícia de Almeida, Alexandre L N da Silva, Tamara S Rodrigues, et al.Vascular Pharmacology|November 28, 2021
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damageTiago J Costa, Simone R Potje, Thais F C Fraga-Silva, et al.The Journal of Experimental Medicine|November 24, 2020
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patientsTamara S Rodrigues, Keyla S G de Sá, Adriene Y Ishimoto, et al.Pageof 1